✦ LIBER ✦

RS2 COST-EFFECTIVENESS OFTELITHROMYCIN IN THE TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA

✍ Scribed by LJ McGarry; R Iskandar; B Seal; C Asche; D Thompson; MC Weinstein

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Effectiveness of Procalcitonin-Guid

✍ Kenneth J. Smith MD, MS, Angela Wateska MPH… 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 427 KB

PHV22: UTILIZATION AND COST-EFFECTIVENES

✍ O Karpov; A Zaytsev 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

Gemifloxacin as first line treatment for

✍ Galindo-Suárez, R.M.; Salinas-Escudero, G.; Muciño-Ortega, E. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Cost-Effectiveness of Sparfloxacin Compa

✍ Mr. Mohammad M. Najib; Dr. Gary E. Stein; Dr. Thomas F. Goss 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB

Glucocorticoid treatment in community-ac

✍ Marco Confalonieri; G Umberto Meduri 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 50 KB

A cost-effectiveness analysis of antimic

✍ Martin, Monique; Moore, Lee; Quilici, Sibilia; Decramer, Marc; Simoens, Steven 📂 Article 📅 2008 🏛 Informa plc 🌐 English ⚖ 673 KB